| Dermal Neoplasm studied in …STUDIED_INderived45 of 45show fewer |
|---|
| → studied in | NCT04577755Phase 2 · active not recruiting Pomalidomide Treatment in Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Skin Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00050752recruiting Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339738Phase 2 · active not recruiting Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Skin Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07716735Phase 1 · not yet recruiting Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Skin Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Atypical Fibroxanthoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03069378Phase 2 · active not recruiting A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Atypical Fibroxanthoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07646080Phase 2 · not yet recruiting Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02799485Phase 2 · completed sEphB4-HSA in Treating Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Skin Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07539454Phase 2 · not yet recruiting Nirogacestat in Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Skin Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07102394Phase 1 · recruiting Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1 · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03601806Phase 2 · completed Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Skin Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06159166Phase 1/Phase 2 · recruiting Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007273Phase 2 · recruiting Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05005845Phase 2 · completed NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05846724Phase 2 · withdrawn Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Classic Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00975819Phase 2 · completed Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Tufted Hemangioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03077451Phase 2 · completed Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Skin Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05581511active not recruiting Natural History Study of Cutaneous Neurofibromas in People With NF1 · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730583Phase 1 · completed Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06610071Phase 1 · not yet recruiting NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Fibrosarcomatous Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05438290Phase 1 · completed DPCP to Treat Cutaneous Neurofibromas Associated With NF1 · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839720Phase 2 · completed Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02110069Phase 2 · terminated A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Tufted Hemangioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05534854unknown Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03921073Phase 2 · terminated Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540566completed Optical Biopsy of Human Skin in Conjunction With Laser Treatment · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Fibrous Histiocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04435665Phase 2 · completed NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346164Phase 3 · completed Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03381846NA · completed Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02310503completed Spanish Registry of Mohs Surgery · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01962103Phase 1/Phase 2 · completed Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03219671Phase 2 · unknown Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS) · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Classic Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659360Phase 2 · completed AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01984892Phase 2 · terminated Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03090971Phase 2 · completed Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171912Phase 2 · completed Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01059656Phase 2 · terminated Phase II Pazopanib Study in Advanced Dermatofibrosarcomas · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720174Phase 1 · completed Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00521092Phase 2 · withdrawn Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Classic Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084630Phase 2 · completed Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243191Phase 2 · completed Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans · condition mapped ONTOLOGY_EXACT · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00122473Phase 1/Phase 2 · completed Imatinib in Dermatofibrosarcoma Protuberans (DFSP) · condition mapped ALIAS · 45 trials mapped (14 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |